Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis

Practitioners commonly use amikacin in patients with cystic fibrosis. Establishment of the pharmacokinetics of amikacin in adults with cystic fibrosis may increase the efficacy and safety of therapy. This study was aimed to establish the population pharmacokinetics of amikacin in adults with cystic...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Illamola, Sílvia M., Huynh, Hoa Q., Liu, Xiaoxi, Bhakta, Zubin N., Sherwin, Catherine M., Liou, Theodore G., Carveth, Holly, Young, David C.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2018
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6153835/
https://ncbi.nlm.nih.gov/pubmed/30061295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00877-18
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki